Atlas Trials

Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

Clinical trial NCT03391804 · COMPLETED

Trial details

NCT number
NCT03391804
Sponsor
Allena Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Enteric HyperoxaluriaPrimary HyperoxaluriaHyperoxalemia
Start date
2018-07-17
Primary completion
2019-12-13
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.